Malignant glaucoma represents a challenging ophthalmic condition with potential for disabling visual morbidity. However, if the condition is diagnosed in a timely fashion and treated appropriately, favorable outcomes may be attained. Malignant glaucoma typically presents intra- or postoperatively with progressive anterior chamber shallowing, progressive myopia, and increased intraocular pressure. The condition results from a cascade of events incited by surgical ocular decompression. Prophylaxis of the condition involves achievement of intraoperative intraocular pressure maintenance. Medical, laser, and surgical therapeutic methods have been described. Medical options involve cycloplegic and aqueous suppression agents. Laser options include YAG laser iridozonulohyaloidotomy and diode laser cyclophotocoagulation. Surgical options include anterior or posterior iridozonulohyaloidotomy and anterior chamber reformation with intraocular lens pushback. Core vitrectomy is not an effective standalone treatment. Surgical therapies offer definitive treatment for this potentially devastating condition.
Glaucoma Malignant glaucoma Iridozonulohyaloidotomy Surgery Glaucoma surgery
This is a preview of subscription content, log in to check access.
Compliance with Ethical Requirements
Devesh K Varma and Iqbal Ike K Ahmed declare that they have no conflict of interest. All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000. Informed consent was obtained from all patients for being included in the study. No animal studies were carried out by the authors for this article.
∎∎∎ (MV4 202,008 kb)
Von Graefe A. Beitrage zur Pathologie und Therapie des Glaucomas. Albrecht Von Graefes Arch Ophthalmol. 1869;15(1):108–252.CrossRefGoogle Scholar